A brand new dialysis filter manufacturing facility is about to start operations in Egypt this July, with the goal of lowering the nation’s reliance on imported medical provides.
The manufacturing unit, developed at a reported price of EGP 160 million (USD 3.3 million), is predicted to fulfill 65 p.c of native demand for dialysis filters. Officers estimate that the transfer may scale back import bills by as much as EGP 3 billion (USD 50 million) yearly.
The announcement was made by Amr Abdel Razek, Chairperson of Wadi El Nile Stio and SLS Egypt, throughout a current press convention on Monday 30 June. He acknowledged that the manufacturing unit has acquired ISO certification and conforms to present worldwide requirements for medical manufacturing.
Whereas the corporate at present imports uncooked supplies from Germany, there are plans to transition to full native manufacturing inside a yr. This shift is intended to scale back reliance on overseas suppliers and assist the resilience of the nationwide healthcare system.
In response to Abdel Razek, round 90 p.c of dialysis filters utilized in Egypt have been beforehand imported. The brand new facility is predicted to considerably scale back that determine by growing home output.
Wadi El Nile Stio and SLS Egypt additionally plan to increase into pharmaceutical manufacturing, specializing in crucial care medicines, together with these utilized in anesthesia, intensive care, and cardiology. The corporate experiences that 40 p.c of those medicines are already produced domestically in compliance with World Well being Group (WHO) requirements. Future plans embrace exporting these merchandise to close by markets to generate overseas income.
To assist the expansion of its operations, the corporate is working with German specialists to implement coaching applications aimed toward transferring technical information and constructing native experience.
Abdel Razek additionally announced the upcoming launch of twenty-two pharmaceutical merchandise, that are anticipated to be priced as much as 60 p.c decrease than comparable imported alternate options. That is a part of an effort to enhance the supply of reasonably priced medicine in Egypt.
In partnership with El Nasr Pharmaceutical Chemical substances Firm, the companies are revamping manufacturing traces for anesthetic medicine and exploring the event of extra services to assist the modernization of the pharmaceutical trade.
The dialysis filters and different merchandise will likely be provided to the Egyptian Unified Procurement Authority (UPA). Moreover, there are plans to ascertain upkeep facilities for dialysis filters throughout a number of governorates and create a specialised unit to service dialysis gear.
This manufacturing unit is a part of a joint initiative based mostly on agreements signed in June 2023 between El Nasr Pharmaceutical Chemical substances Firm and Wadi El Nile Stio Life Science to revive and function an current however inactive manufacturing web site.